Skip to main content
. 2011 Nov 9;36(2):277–283. doi: 10.1007/s00264-011-1398-0

Fig. 1.

Fig. 1

Proportion of resistance to anti-tuberculosis drugs among MDR-TB and non-MDR-TB patients. Number of patients was 35. MDR-TB multi-drug resistant tuberculosis, Non-MDR-TB non-multi-drug resistant tuberculosis, INH isoniazid, RFP rifampin, EMB ethambutol, SM streptomycin, LVFX levofloxacin, PAS para-aminosalicylic acid, AMK amikacin, CPM capreomycin Pto protionamide, Dip pasiniazid, RPT rifapentine